FASN and posterior cortical atrophy: In summary, the present study revealed the underlying mechanism by which darolutamide induces ferroptosis through the SREBP1-FASN axis in PCa, suggesting that the combination of darolutamide with FINs could be a promising therapeutic strategy for PCa patients with AR mutations.